Bladder tumor markers:from hematuria to molecular diagnostics-where do we stand-〔J〕. Shirodkar SP,Lokeshwar VB. Expert Rev Anti-cancer Ther . 2008Shirodkar SP, Lokeshwar VB. Bladder tumor markers: from hematuria to molecular diagnostics- where do we stand? [ J] . Expert Rev Anticancer...
Table9.2Targetsfordiagnosticmonoclonalantibodies•Polypeptidehormones(humanchorionicgonadotropin(hCG),growthhormone)•Tumormarkers(Prostate-specificantigen)•Cytokines(interleukins1-8)•Drugmonitoring(cyclosporin)•Miscellaneoustargets(VitaminB12)•Infectiousdiseases(Chlamydia,Herpes,Rubella,HepatitisB,Legionella,...
Diasorin is the global leader in Molecular Diagnostics and Immunodiagnostics market. Discover all Diasorin’s diagnostic solutions.
Tumor Markers Instruments Instruments LIAISON® XL LIAISON® XS Events Dialog Molecular Diagnostics Molecular Diagnostics Overview Technologies Technologies VERIGENE® NanoGrid Technology Simplexa™ Real-Time PCR xTAG® and NxTAG® Technology Instruments Instruments ...
Finally, we investigated the mutational burden on the entire genome with regards to epigenetics. To estimate the mutational burden, we tabulated the number of mutations observed in functional genomic regions as defined by epigenetic markers. We used ChromHMM [33] to segment the genome into 15 basic...
Biomarkers in molecular medicine: cancer detection and diagnosis In spite of advances in diagnostics and therapeutics, cancer remains the second leading cause of death in the U.S. Successful cancer treatment depends not ... M Padma,W Wang,PD Wagner,... - 《Biotechniques》 被引量: 73发表: ...
These genetic variants have the potential to affect signaling pathways that play important roles in mood disorder etiology. They could be promising targets for developing diagnostics and preventive drugs for mood disorders. Thus, this study aimed to identify the hub genetic variations and their ...
Celnovte Biotechnology, a leading high-tech enterprise, excels in tumor pathology and IVD. We specialize in R&D, manufacturing, and distribution of pathological diagnostic tools
et al. Circulating tumor cells as prognostic markers in neuroendocrine tumors. J. Clin. Oncol. 31, 365–372 (2013). Article CAS PubMed Google Scholar Khoja, L. et al. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma. J. Invest. Dermatol. 133, 1582–1590 (2013...
we present the consensus of the INRG Biology Committee on which markers should be used currently, on the standardised operating procedures (SOPs; partly on the basis of SIOPEN activities (Ambros et al, 2003)) for analysing neuroblastoma tumour molecular diagnostics and genetic nomenclature in this ...